GSK’s contribution to the fight against corona
14 April 2020
GSK and Sanofi join forces in unprecedented vaccine collaboration to fight COVID-19
Companies to combine innovative technologies to develop an adjuvanted COVID-19 vaccine. Candidate vaccine expected to enter clinical trials in the second half of 2020 and, if successful, to be available in the second half of 2021.
8 April 2020
GSK's major contributions to the fight against Covid-19 in Belgium: a minimum of 6000 screening tests per day and a donation of ten tons of protective equipment
GSK brings its expertise by carrying out tests in its laboratories against the coronavirus, thus participating in a significant increase of the number of analyzes in our country. GSK will be able to carry 6.000 tests per day. On top of this commitment we added the donation of ten tons of protective equipment. Local actions that join other initiatives and research projects carried out internationally by the company to fight the pandemic.
20 March 2020
For the most recent information on how GSK contributes to fight against the coronavirus, please find the link to the global website which is regularly updated.